{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"ISRCTN","place":["London, UK"]}],"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T16:02:01Z","timestamp":1746806521152,"version":"3.40.5"},"reference-count":0,"publisher":"Springer Science and Business Media LLC","funder":[{"DOI":"10.13039\/501100001306","name":"Health Protection Agency (HPA) (UK)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council (MRC) (UK)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.isrctn.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1186\/isrctn94465371","type":"dataset","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T06:21:43Z","timestamp":1434694903000},"update-policy":"https:\/\/doi.org\/10.1186\/isrctn_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PRe-exposure Option for reducing HIV in the UK: an open-label randomisation to immediate or Deferred daily Truvada for HIV negative gay men"],"prefix":"10.1186","author":[{"given":"Sheena","family":"McCormack","sequence":"first","affiliation":[]}],"member":"297","content-created":{"date-parts":[[2013,2,28]]},"container-title":["http:\/\/isrctn.com\/"],"original-title":[],"deposited":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T06:21:43Z","timestamp":1434694903000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.isrctn.com\/ISRCTN94465371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,28]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1186\/isrctn94465371","relation":{},"subject":[],"published":{"date-parts":[[2013,2,28]]}}}